Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026)
Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.62 Bn | 121.41 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.86 Bn | 44.04 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.19 Bn | 22.76 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn | 84.02% |
| 10 | Nephros | 36.43 Mn | 32.41 Mn | 2.99 Mn | -530.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -530.53% |
| Dec 31, 2025 | -85.88% |
| Sep 30, 2025 | 115.57% |
| Jun 30, 2025 | 297.42% |
| Mar 31, 2025 | 147.63% |
| Dec 31, 2024 | 572.10% |
| Sep 30, 2024 | -204.18% |
| Jun 30, 2024 | -324.55% |
| Mar 31, 2024 | -433.66% |
| Dec 31, 2023 | 9.80% |
| Sep 30, 2023 | 350.21% |
| Jun 30, 2023 | 118.04% |
| Mar 31, 2023 | 113.03% |
| Dec 31, 2022 | 17.74% |
| Sep 30, 2022 | 74.19% |
| Jun 30, 2022 | -1,189.47% |
| Mar 31, 2022 | -1,813.58% |
| Dec 31, 2021 | -112.04% |
| Sep 30, 2021 | 51.13% |
| Jun 30, 2021 | 106.74% |